EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Timing and clinical significance of chemotherapy in patients with resected gastric adenocarcinoma: a population-based cohort study

Di Zhang, Qian Yang, Chunwang Ji, Xue Zhang, Xinyu Song, Zhaodi Nan, Qian Xu, Shulun Nie, Jianyuan Zhou, Jiahui Chu, Liliang Dou, Fan Jiang und 5 weitere

The Oncologist · 2025

DOI: 10.1093/oncolo/oyaf179 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift The Oncologist, 2025. Verfasst von Di Zhang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, People's Republic of China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Adenocarcinoma. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study was to assess the impact of chemotherapy sequence on the prognosis of patients with gastric cancer (GC) undergoing gastrectomy and identify optimal chemotherapy timing along with potential candidates. Patients and methods Data on patients who underwent gastrectomy were extracted from Surveillance, Epidemiology, and End Results database. Prognostic factors for overall survival (OS) were assessed using Kaplan-Meier and Cox regression analyses. Treatment strategies were categorized into neoadjuvant chemotherapy (NAC), adjuvant chemotherapy (AC), and perioperative chemotherapy (PC), with subsequent analyses of clinical outcomes. Stable inverse probability of treatment weighting (sIPTW) and subgroup analyses were conducted to evaluate the significance of chemotherapy timing.

Results

Among 4914 patients, 38.4% received NAC, 45% received AC, and 16.6% received PC. The 5-year OS rates for the entire cohort were 41.2%. Although no significant differences were observed between NAC and AC, PC exhibited a substantial improvement in OS compared to both. Multivariate analysis highlighted chemotherapy timing as a prognostic factor for OS. Even after sIPTW, PC still demonstrated significantly longer OS compared to NAC and AC, and this trend persisted across almost all subgroups. Even after patients underwent NAC and gastrectomy, AC remained essential. Notably, potential candidates exempt from AC were identified, including patients aged ≥65 years and those with tumor grades I-II.

Conclusions

Chemotherapy timing was an independent prognostic factor for resected GC. PC presented as a promising strategy, displaying superior OS compared to both NAC and AC. However, older individuals and those with well-differentiated tumors could be considered exempt from further AC after receiving NAC and gastrectomy. Further research is needed to validate these findings and optimize GC management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsAdenocarcinomaHumansMaleFemaleMiddle AgedAgedGastrectomyChemotherapy, AdjuvantPrognosisNeoadjuvant TherapyCohort StudiesAdultSEER ProgramAged, 80 and overClinical Relevance

Stichwörter der Autor:innen

adjuvant chemotherapyand end results databaseepidemiologygastric cancerneoadjuvant chemotherapyperioperative chemotherapysurveillancesurvival

Autor:innen und Institutionen

  • Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, People's Republic of China.
  • Institute of Marine Science and Technology, Shandong University, Qingdao, 266237, People's Republic of China.

ORCID-Profile: Lian Liu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, D., Yang, Q., Ji, C., Zhang, X., Song, X., Nan, Z., Xu, Q., Nie, S., Zhou, J., Chu, J., Dou, L., Jiang, F., Jiao, J., Hu, Q., Wu, X., Li, S., & Liu, L. (2025). Timing and clinical significance of chemotherapy in patients with resected gastric adenocarcinoma: a population-based cohort study. The Oncologist. https://doi.org/10.1093/oncolo/oyaf179

Vancouver

Zhang D, Yang Q, Ji C, Zhang X, Song X, Nan Z, et al. Timing and clinical significance of chemotherapy in patients with resected gastric adenocarcinoma: a population-based cohort study. The Oncologist. 2025. doi:10.1093/oncolo/oyaf179

BibTeX
@article{Zhang2025,
  author = {Zhang, Di and Yang, Qian and Ji, Chunwang and Zhang, Xue and Song, Xinyu and Nan, Zhaodi and Xu, Qian and Nie, Shulun and Zhou, Jianyuan and Chu, Jiahui and Dou, Liliang and Jiang, Fan and Jiao, Jianqiao and Hu, Qinqin and Wu, Xuehui and Li, Song and Liu, Lian},
  title = {Timing and clinical significance of chemotherapy in patients with resected gastric adenocarcinoma: a population-based cohort study},
  journal = {The Oncologist},
  year = {2025},
  doi = {10.1093/oncolo/oyaf179}
}
Kostenlos starten →